Position in LLY
as of Jun 30, 2026
· filed Jul 31, 2026
Position Value
$24,910,963
+$5,807,341 QoQ
Shares Held
20,769
-0.0% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
3.01%
of 13F equity value
Holder Rank
#807
of 4,605 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 97%
Shared 0%
None 3%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Rossmore Private Capital holds $82,109,326 across 11 Drug Manufacturers - General names. LLY ranks #2 (30.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
100,877 | $25,619,731 | |
| 2 | LLY |
ELI LILLY & Co
This page
|
20,769 | $24,910,963 | |
| 3 | ABBV |
AbbVie Inc.
|
46,722 | $11,757,124 | |
| 4 | MRK |
Merck & Co., Inc.
|
57,121 | $7,340,048 | |
| 5 | AZN |
Astrazeneca PLC
|
37,843 | $7,175,789 | |
| 6 | AMGN |
Amgen Inc
|
5,635 | $2,040,546 | |
| 7 | NVO |
Novo Nordisk A S
|
23,000 | $1,102,620 | |
| 8 | NVS |
Novartis AG
|
4,581 | $717,934 |
All Filings in LLY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $24,910,963 | 20,769 | Shares | Sole | 2026-07-31 | |
| 2026-03-31 | $19,103,622 | 20,770 | Shares | Sole | 2026-05-01 | |
| 2025-12-31 | $22,505,950 | 20,942 | Shares | Sole | 2026-02-05 | |
| 2025-09-30 | $15,788,759 | 20,693 | Shares | Sole | 2025-10-30 | |
| 2025-06-30 | $15,980,365 | 20,500 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $16,966,669 | 20,543 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $15,138,148 | 19,609 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $16,963,979 | 19,148 | Shares | Sole | 2024-11-05 | |
| 2024-06-30 | $17,305,433 | 19,114 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $14,590,639 | 18,755 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $10,142,808 | 17,400 | Shares | Sole | 2024-02-07 | |
| 2023-09-30 | $9,303,091 | 17,320 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $8,149,934 | 17,378 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $5,979,972 | 17,413 | Shares | Sole | 2023-05-02 | |
| 2022-12-31 | $6,278,911 | 17,163 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $5,544,482 | 17,147 | Shares | Sole | 2022-11-08 | |
| 2022-06-30 | $5,544,981 | 17,102 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $4,825,907 | 16,852 | Shares | Sole | 2022-05-09 | |
| 2021-12-31 | $4,515,920 | 16,349 | Shares | Sole | 2022-02-07 | |
| 2021-09-30 | $3,762,418 | 16,284 | Shares | Sole | 2021-11-08 | |
| 2021-06-30 | $3,781,342 | 16,475 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $3,021,626 | 16,174 | Shares | Sole | 2021-05-10 | |
| 2020-12-31 | $2,461,687 | 14,580 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $2,127,491 | 14,373 | Shares | Sole | 2020-11-10 | |
| 2020-06-30 | $1,938,637 | 11,808 | Shares | Sole | 2020-08-05 | |
| 2020-03-31 | $1,428,261 | 10,296 | Shares | Sole | 2020-05-07 | |
| No filing history on record for this holder in this stock. | ||||||